IL-4R

11개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved11 programs
AntibodyCurated CoreFDANovo NordiskApproved

semaglutide (Ozempic / Wegovy, GLP-1, Wegovy, NN9535)

Type 2 diabetes, chronic weight management, CV risk reduction (T2D) · GLP-1 receptor

#GLP-1receptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 410Status Approved
AntibodyCurated CoreFDASanofiApproved

dupilumab (Dupixent, REGN668)

Atopic dermatitis, asthma, CRSwNP, EoE, prurigo nodularis · IL-4Rα

#IL-4R#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 278Status Approved
AntibodyCurated CoreFDAEli LillyApproved

tirzepatide (Mounjaro / Zepbound, Mounjaro, Zepbound, LY3298176)

Type 2 diabetes, chronic weight management · GLP-1 / GIP receptor

#GLP-1GIPreceptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 269Status Approved
CGTLimited DatastaleThe Affiliated Hospital of Xuzh…Preclinical

GLP-1 receptor agonist (GLP-1 receptor agonist)

Type 2 Diabetes Mellitus; Susceptibility, Genetic · Type 2 Diabetes Mellitus

#Type2DiabetesMellitus#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 31Status Recruiting
AntibodyLimited DatastaleSanofiPreclinical

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis With Nasal Polyps

#ChronicRhinosinusitisWithNasalPo#Antibody#Preclinical#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleSanofiPhase 1

dupilumab (DUPIXENT®, DUPIXENT® (dupilumab))

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleSanofiPhase 2

REGN3500 + Dupilumab Combo (REGN3500 + Dupilumab Combo)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Phase2#monoclonal-antibody#Sanofi
Trials 1Status Discontinued
AntibodyLimited DatastaleSanofiApproved

Stopping dupilumab (Stopping dupilumab)

Severe Asthma · Severe Asthma

#SevereAsthma#Antibody#Approved#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleSanofiPreclinical

Systemic dupilumab (Systemic dupilumab)

Dermatitis, Atopic · Dermatitis, Atopic

#DermatitisAtopic#Antibody#Preclinical#monoclonal-antibody#Dermatitis+2
Trials 1Status Active
AntibodyLimited DatastaleSanofiApproved

Vanicream- Dupilumab-naïve (Vanicream- Dupilumab-naïve)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#monoclonal-antibody#Sanofi
Trials 1Status Active
AntibodyLimited DatastaleSanofiApproved

Vanicream- Experienced Dupilumab (Vanicream- Experienced Dupilumab)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#monoclonal-antibody#Sanofi
Trials 1Status Active